Clinical Trial Update: Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating alendronate for osteoporosis in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Rheumatoid Arthritis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: University of Aarhus | Conditions: Rheumatoid Arthritis, Osteoporosis | Phase 2 | Status: COMPLETED